KB Investment

About

Portfolio · 3

Kardome Technology

Voice User Interface Technology

1 round $10.0M committed Latest: 2024-11

BioProtect

Developer of a biodegradable balloon implant for prostate cancer radiation therapy.

1 round $25.0M committed Latest: 2020-09

BiomX

Microbiome Therapies for Chronic Diseases

1 round $32.0M committed Latest: 2019-02

Investment activity

2 portfolio exits on record.

Q&A

What is KB Investment's primary focus in terms of investment stages?

KB Investment primarily focuses on Seed, A Round, B Round, and C Round investments.

Which sectors does KB Investment prioritize for its investments?

KB Investment prioritizes investments in sectors such as consumer products, healthcare, information technology, and clean tech.

Has KB Investment had any notable exits in the health tech sector?

Yes, KB Investment had an exit in January 2026 with the acquisition of BioProtect by Almeda Ventures for $200M. Another notable exit was BiomX, which went public via a reverse merger in November 2019.

Can you name some of KB Investment's portfolio companies?

KB Investment's portfolio includes BioProtect and BiomX

What is the geographic focus of KB Investment?

KB Investment invests in companies across the United States, Southeast Asia, and Israel.

When was KB Investment founded and where is it headquartered?

KB Investment was founded in 1990 and is headquartered in Seoul, South Korea.

What is KB Investment's investment range?

KB Investment's investment range is between $10M and $32M.

What type of technology does portfolio company Kardome Technology develop?

Kardome Technology, a portfolio company of KB Investment, develops voice user interface technology.